HIV & STIs
HIV & STIs 12/03/2010
Nucleic аcid аmplification testing detects extragenital STIs missed by cultures in young HIV-infected patients
Nucleic acid amplification testing (NAAT) for gonorrhea and chlamydia at extragenital sites might detect more positive cases than does the use of cultures at these sites, according to a new study.
HIV & STIs 04/03/2010
Beliefs about reduced infection risk on ART linked to STI risk
People who believed that having undetectable viral load on antiretroviral therapy reduces the risk of passing on HIV were more likely to have a sexually transmitted infection in a US study, published this week in HIV Medicine.
HIV & STIs 17/02/2010
Phase III study: GARDASIL prevents 77.5% of pre-cursor lesions to anal cancer
In a new phase III study, GARDASIL prevented 77.5 per cent of anal intraepithelial neoplasia associated with human papillomavirus types 6, 11, 16 and 18 in 16-to-26 year-old men who have sex with men.
HIV & STIs 16/02/2010
Herpes therapy slows HIV progression
Treating herpes simplex type 2 (HSV-2) slows the progression of HIV in people infected with both, researchers have found.
HIV & STIs 13/02/2010
Syphilis does not worsen HIV disease progression
Concurrent infection with syphilis does not lead to accelerated HIV disease progression, even though it may be associated with temporary changes in CD4 cell count and HIV viral load, according to a study reported in the January 2010 International Journal of STD & AIDS.
HIV & STIs 11/02/2010
HIV treatment might increase clearance of HPV infection in women
Women living with HIV who regularly take antiretroviral therapy may be more likely to clear human papillomavirus and cervical lesions than women who don’t consistently take their meds.
HIV & STIs 21/01/2010
Herpes therapy doesn't bar HIV transmission
Treating herpes has no effect on the transmission of HIV among discordant couples, researchers said.
HIV & STIs 15/01/2010
Merck submits Gardasil data for women 27 to 45
Merck & Co on Wednesday said it had provided U.S. regulators with new information needed for approval to market its Gardasil cervical cancer vaccine to women between the ages of 27 to 45.
HIV & STIs 04/12/2009
Cervarix provides long duration of protection against HPV 16 and 18
According to new data published online December 3 in The Lancet, the HPV 16/18 AS04-adjuvanted vaccine offered sustained protection and long-term efficacy for up to 6.4 years.
HIV & STIs 19/11/2009
Circumcision may protect HIV-negative gay men from syphilis
Circumcision protects HIV-negative gay men from infection with syphilis, Australian investigators report in the December 15th edition of the Journal of Infectious Diseases. However, circumcision did not affect the risk of acquiring any other sexually transmitted infection.
HIV & STIs 18/11/2009
Asymptomatic chlamydia more prevalent in HIV-negative than HIV-positive men
A study conducted at a primary care clinic in Berlin, Germany, of men who have sex with men found that HIV-negative men had a higher prevalence of asymptomatic Chlamydia trachomatis infection than HIV-positive men, contrary to expectation.
HIV & STIs 16/11/2009
Precancerous anal lesions may be very common in some populations: protease inhibitor therapy may help
Two presentations at the EACS Conference in Cologne investigating anal cancer have found very different levels of the anal dysplasia (cellular changes) that may lead to anal cancer in HIV-positive patients.
HIV & STIs 14/11/2009
HPV therapeutic vaccine works in an early trial
A therapeutic vaccine designed to help the immune system better control human papillomavirus was nearly 50 percent effective in eliminating precancerous genital lesions.
HIV & STIs 12/11/2009
Changes in sexual behaviour and HIV risk
While HAART has had a profound impact on the health and lives of HIV-positive people, it may have had an inadvertent impact on HIV-negative people.
HIV & STIs 12/11/2009
Topical treatment works well for anal lesions
Trichloroacetic acid, a topical liquid sometimes used to treat genital warts, may also be useful as a therapy for anal intraepithelial neoplasia in HIV-positive and HIV-negative people.
HIV & STIs 01/11/2009
Traditional Pap smears work as well as ThinPrep cytology test for detecting precancerous cervical cell changes
Conventional Pap smears can detect cervical neoplasia, or precancerous cell changes, as well as the newer ThinPrep liquid-based cytology test, indicating that both methods effectively predict cervical cancer.
HIV & STIs 29/10/2009
High prevalence of anal chlamydia in Swiss HIV-positive gay men
A large proportion of HIV-positive gay men in Switzerland have anorectal infection with chlamydia, investigators report in the November 15th edition of Clinical Infectious Diseases.
HIV & STIs 22/10/2009
Glaxo says U.S. panel recommends Cervarix vaccine
The Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices recommended routine administration of Cervarix among 11- and 12-year-old girls as well as for older girls and young women who have not been vaccinated. That includes females ages 13 to 25.
HIV & STIs 22/10/2009
HPV vaccine fails to get nod for routine use in boys
Despite hearing impassioned pleas to protect both men and women from cancer, a federal advisory panel today declined to recommend that a human papillomavirus (HPV) vaccine be routinely administered to boys to prevent genital warts.
HIV & STIs 17/10/2009
U.S. OKs Glaxo's cervical cancer shot
GlaxoSmithKline Plc won U.S. approval on Friday to sell a cervical cancer vaccine for girls and young women, while a rival Merck & Co shot was cleared for preventing genital warts in males.
More...
